121 related articles for article (PubMed ID: 2926498)
21. Treatment of human brain tumor xenografts with O6-benzyl-2'-deoxyguanosine and BCNU.
Schold SC; Kokkinakis DM; Rudy JL; Moschel RC; Pegg AE
Cancer Res; 1996 May; 56(9):2076-81. PubMed ID: 8616853
[TBL] [Abstract][Full Text] [Related]
22. Potentiation of nitrosourea cytotoxicity in human leukemic cells by inactivation of O6-alkylguanine-DNA alkyltransferase.
Gerson SL; Trey JE; Miller K
Cancer Res; 1988 Mar; 48(6):1521-7. PubMed ID: 3162197
[TBL] [Abstract][Full Text] [Related]
23. O6-Alkylguanine-DNA alkyltransferase activity correlates with the therapeutic response of human rhabdomyosarcoma xenografts to 1-(2-chloroethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosourea.
Brent TP; Houghton PJ; Houghton JA
Proc Natl Acad Sci U S A; 1985 May; 82(9):2985-9. PubMed ID: 3857628
[TBL] [Abstract][Full Text] [Related]
24. Glial cell-specific differences in repair of O6-methylguanine.
LeDoux SP; Williams BA; Hollensworth BS; Shen C; Thomale J; Rajewsky MF; Brent TP; Wilson GL
Cancer Res; 1996 Dec; 56(24):5615-9. PubMed ID: 8971165
[TBL] [Abstract][Full Text] [Related]
25. Modulation of O6-alkylguanine-DNA alkyltransferase in rats following intravenous administration of O6-methylguanine.
Dexter EU; Yamashita TS; Donovan C; Gerson SL
Cancer Res; 1989 Jul; 49(13):3520-4. PubMed ID: 2731174
[TBL] [Abstract][Full Text] [Related]
26. O6-alkylguanine-DNA alkyltransferase activity in human brain tumors.
Frosina G; Rossi O; Arena G; Gentile SL; Bruzzone E; Abbondandolo A
Cancer Lett; 1990 Dec; 55(2):153-8. PubMed ID: 2265415
[TBL] [Abstract][Full Text] [Related]
27. Response of cultured human cell lines from rhabdomyosarcoma xenografts to treatment with chloroethylnitrosoureas.
Smith DG; Brent TP
Cancer Res; 1989 Feb; 49(4):883-6. PubMed ID: 2521455
[TBL] [Abstract][Full Text] [Related]
28. Activity of temozolomide in the treatment of central nervous system tumor xenografts.
Friedman HS; Dolan ME; Pegg AE; Marcelli S; Keir S; Catino JJ; Bigner DD; Schold SC
Cancer Res; 1995 Jul; 55(13):2853-7. PubMed ID: 7796412
[TBL] [Abstract][Full Text] [Related]
29. Repair of O6-alkylguanine during DNA synthesis in murine bone marrow hematopoietic precursors.
Gerson SL; Trey JE; Miller K; Benjamin E
Cancer Res; 1987 Jan; 47(1):89-95. PubMed ID: 3539320
[TBL] [Abstract][Full Text] [Related]
30. Enhanced repair of O6-methylguanine DNA adducts in the liver of transgenic mice expressing the ada gene.
Dumenco LL; Arce C; Norton K; Yun J; Wagner T; Gerson SL
Cancer Res; 1991 Jul; 51(13):3391-8. PubMed ID: 2054779
[TBL] [Abstract][Full Text] [Related]
31. Rapid repair of O6-methylguanine-DNA adducts protects transgenic mice from N-methylnitrosourea-induced thymic lymphomas.
Liu L; Allay E; Dumenco LL; Gerson SL
Cancer Res; 1994 Sep; 54(17):4648-52. PubMed ID: 8062258
[TBL] [Abstract][Full Text] [Related]
32. Inter- and intracellular heterogeneity of O6-alkylguanine-DNA alkyltransferase expression in human brain tumors: possible significance in nitrosourea therapy.
Lee SM; Reid H; Elder RH; Thatcher N; Margison GP
Carcinogenesis; 1996 Apr; 17(4):637-41. PubMed ID: 8625471
[TBL] [Abstract][Full Text] [Related]
33. Measurement of O6-alkylguanine-DNA alkyltransferase activity in human cells and tumor tissues by restriction endonuclease inhibition.
Wu RS; Hurst-Calderone S; Kohn KW
Cancer Res; 1987 Dec; 47(23):6229-35. PubMed ID: 2824027
[TBL] [Abstract][Full Text] [Related]
34. Novel, sensitive assays for O6-alkylguanine and its repair and their application to studies of the molecular epidemiology of this lesion in human populations.
Kyrtopoulos SA; Souliotis VL; Ambatzi P; Pangalis G; Bousiotou V; Haritopoulos G; Davaris G
IARC Sci Publ; 1991; (105):78-82. PubMed ID: 1855926
[TBL] [Abstract][Full Text] [Related]
35. Specificity of O6-alkylguanine-DNA alkyltransferase.
Pegg AE; Scicchitano D; Morimoto K; Dolan ME
IARC Sci Publ; 1987; (84):30-4. PubMed ID: 3679391
[TBL] [Abstract][Full Text] [Related]
36. DNA adduct dosimetry and DNA repair in rats and pigs given repeated doses of procarbazine under conditions of carcinogenicity and human cancer chemotherapy respectively.
Fong LY; Bevill RF; Thurmon JC; Magee PN
Carcinogenesis; 1992 Nov; 13(11):2153-9. PubMed ID: 1423888
[TBL] [Abstract][Full Text] [Related]
37. Combined modality treatment using radiation and/or chemotherapy in an athymic nude mouse-human medulloblastoma and glioblastoma xenograft model.
Slagel DE; Feola J; Houchens DP; Ovejera AA
Cancer Res; 1982 Mar; 42(3):812-6. PubMed ID: 7059979
[TBL] [Abstract][Full Text] [Related]
38. Accumulation of O6-methylguanine in human DNA after therapeutic exposure to methylating agents and its relationship with biological effects.
Kyrtopoulos SA; Souliotis VL; Valavanis C; Boussiotis VA; Pangalis GA
Environ Health Perspect; 1993 Mar; 99():143-7. PubMed ID: 8319612
[TBL] [Abstract][Full Text] [Related]
39. Efficient repair of O6-ethylguanine, but not O4-ethylthymine or O2-ethylthymine, is dependent upon O6-alkylguanine-DNA alkyltransferase and nucleotide excision repair activities in human cells.
Bronstein SM; Skopek TR; Swenberg JA
Cancer Res; 1992 Apr; 52(7):2008-11. PubMed ID: 1551130
[TBL] [Abstract][Full Text] [Related]
40. Treatment of human glioma and medulloblastoma tumor lines in athymic mice with diaziquone and diaziquone-based drug combinations.
Schold SC; Friedman HS; Bjornsson TD; Bigner DD
Cancer Res; 1984 Jun; 44(6):2352-7. PubMed ID: 6722774
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
